Evotaz

Active Ingredient(s): Atazanavir + Cobicistat
FDA Approved: * January 29, 2015
Pharm Company: * BRISTOL MYERS SQUIBB
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Evotaz Overview

Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS.[1] It is generally recommended for use with other antiretrovirals.[1] It may be used for prevention after a needlestick injury or other potential exposure.[1] It is taken by mouth once a day.[1] Common side effects include headache, nausea, yellowish skin, abdominal pain, trouble sleeping, and fever.&...

Read more Evotaz Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Atazanavir

Recent Evotaz Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Atazanavir + Cobicistat
  • Tablet: 300 + 150mg, 300mg + 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Evotaz: (3 results)

Sorted by National Drug Code
  • 0003-3641 Evotaz Oral Tablet by E.r. Squibb & Sons, L.L.C.
  • 50090-1724 Evotaz Oral Tablet by A-s Medication Solutions
  • 54569-6595 Evotaz Oral Tablet by A-s Medication Solutions

Drugs with one or more similar ingredients: (12 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 July 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA